ProCE Banner Activity


Asthma Management: Applying Phenotyping and Endotyping to Improve Outcomes in Uncontrolled Asthma


A large proportion of patients with asthma have asthma that is uncontrolled. Many of these patients have symptoms that are uncontrolled despite maximizing available inhaled therapy options. In this 1-hour webcast, national asthma experts review management of severe and uncontrolled asthma, providing detailed insight into the utilization of asthma endotype and phenotype classifications and patient-specific factors for appropriate add-on biologic selection to improve asthma control.

In Collaboration With the Association of Pulmonary Advanced Practice Providers


In Collaboration With the National Association of Pediatric Nurse Practitioners


Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit

Released: January 28, 2022

Expiration: January 27, 2023

No longer available for credit.



Ann Hefel

Ann Hefel, FNP-BC, MS, RN

Department of Pediatrics, Allergy & Immunology
University of Colorado
Aurora, Colorado

Mark Liu

Mark Liu, MD

Associate Professor of Medicine
Division of Pulmonology and Critical Care Medicine
Johns Hopkins University
Baltimore, Maryland

Corinne Young

Corinne Young, MSN, FNP-C, FCCP

The Association of Pulmonary Advanced Practice Providers
Colorado Springs, Colorado


This program is cosupported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Genentech, a member of the Roche Group; GlaxoSmithKline; Jazz Pharmaceuticals, Inc.; and Mylan Specialty L.P.

This activity is supported by educational grants from Genentech, a member of the Roche Group; and GlaxoSmithKline.

Provided by

ProCE Banner

Target Audience

NPs and PAs in pulmonary medicine

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Classify uncontrolled asthma based on phenotypes and endotypes

  • Identify appropriate treatment options with add-on biologic therapy

  • Modify treatment plans based on individual patient- and disease-focused elements


Ms Hefel has no relevant financial relationships to disclose.

Dr Liu: contracted research: GlaxoSmithKline, Gossamer Bio; consulting fees: AstraZeneca, GlaxoSmithKline, Gossamer Bio

Ms Young has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.

Faculty Disclosure

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the evaluation form

The estimated time to complete this activity is 1.00 hour.

Release date: January 28, 2022
Expiration date: January 27, 2023


Interactive video lecture


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.



Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 27, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA Course Advisor: John Hardisty, MS, MSPAS, PA-C, Colorado Springs Pulmonary Consultants, Colorado Springs, Colorado

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.